Simple jQuery Dropdowns

Browsing by Author Supeda Thongyen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)
1-Jan-2014ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimenWeerawat Manosuthi; Chonlaphat Sukasem; Supeda Thongyen; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
21-Jul-2006Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxisWeerawat Manosuthi; Somnuek Sungkanuparph; Supeda Thongyen; Nopphanath Chumpathat; Boonchuay Eampokalap; Unchana Thawornwan; Suporn Foongladda; Bamrasnaradura Infectious Disease Institute; Mahidol University
1-Oct-2009Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampinWeerawat Manosuthi; Somnuek Sungkanuparph; Preecha Tantanathip; Wiroj Mankatitham; Aroon Lueangniyomkul; Supeda Thongyen; Boonchuay Eampokarap; Sumonmal Uttayamakul; Pawita Suwanvattana; Samroui Kaewsaard; Kiat Ruxrungtham; Thailand Ministry of Public Health; Mahidol University; The HIV Netherlands Australia Thailand Research Collaboration; Bamrasnaradura Infectious Diseases Institute
1-Jan-2015Comparison of thai government manufactured tenofovir (Tenofovir GPO300) with privately manufactured tenofovir (Viread) used along with lamivudine and efavirenz to treat Thai HIV patientsWeerawat Manosuthi; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-Jan-2014CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapyWeerawat Manosuthi; Chonlaphat Sukasem; Aroon Lueangniyomkul; Wiroj Mankatitham; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-May-2007Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapySomnuek Sungkanuparph; Boonchuay Eampokalap; Suthat Chottanapund; Supeda Thongyen; Weerawat Manosuthi; Mahidol University; Thailand Ministry of Public Health
1-Feb-2013HIV-1 drug resistance-associated mutations among antiretroviral-naive thai patients with chronic HIV-1 infectionWeerawat Manosuthi; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-Feb-2013Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patientsWeerawat Manosuthi; Chonlaphat Sukasem; Aroon Lueangniyomkul; Wiroj Mankatitham; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
13-Mar-2012Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failureWeerawat Manosuthi; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
1-May-2011Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective studyWeerawat Manosuthi; Aroon Lueangniyomkul; Wiroj Mankatitham; Sukanya Chimsuntorn; Preecha Tantanathip; Supeda Thongyen; Busakorn Suntisuklappon; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
15-Jun-2009A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in hiv-infected patients receiving rifampicin: The n<inf>2</inf>r studyWeerawat Manosuthi; Somnuek Sungkanuparph; Preecha Tantanathip; Aroon Lueangniyomkul; Wiroj Mankatitham; Wisit Prasithsirskul; Sunantha Burapatarawong; Supeda Thongyen; Sirirat Likanonsakul; Unchana Thawornwa; Vilaiwan Prommool; Kiat Ruxrungtham; Thailand Ministry of Public Health; Mahidol University; The HIV Netherlands Australia Thailand Research Collaboration; Chulalongkorn University
1-Mar-2011Single-boosted protease inhibitor versus double-boosted protease inhibitors for the salvage therapy in HIV-infected patientsWeerawat Manosuthi; Sukanya Chimsuntorn; Supeda Thongyen; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University; Bamrasnaradura Infectious Diseases Institute
1-Sep-2006Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapyWeerawat Manosuthi; Suthat Chottanapand; Supeda Thongyen; Achara Chaovavanich; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University; Bamrasnaradura Infectious Disease Institute
1-Aug-2012Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: Results From the TIME studyWeerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Supeda Thongyen; Sirirat Likanonsakul; Pawita Suwanvattana; Unchana Thawornwan; Busakorn Suntisuklappon; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University
23-Dec-2009Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failureWeerawat Manosuthi; Sasisopin Kiertiburanakul; Wannarat Amornnimit; Wisit Prasithsirikul; Supeda Thongyen; Samruay Nilkamhang; Kiat Ruxrungtham; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University; The HIV Netherlands Australia Thailand Research Collaboration; Chulalongkorn University
1-Nov-2010Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: A four-year prospective studyWeerawat Manosuthi; Preecha Tantanathip; Sukanya Chimsuntorn; Boonchuay Eampokarap; Supeda Thongyen; Samruay Nilkamhang; Somnuek Sungkanuparph; Thailand Ministry of Public Health; Mahidol University